SeekingAlphaOctober 19, 2026 at 1:23 PM NY8 Days Ago
Silence Therapeutics: Downgrade To Hold On Merck KGaA Acquisition And PV siRNA
Merck KGaA is to buy Silence Therapeutics plc for $1.3B cash at $20/ADS (130% premium). Click for a look at SLN and see why I am downgrading it.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: SeekingAlpha
